Results 61 to 70 of about 24,788 (241)

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.

Revista Alergia México
Objective: to perform a cost-effectiveness analysis of asthma treatment with budesonide/formoterol against other treatment options used at Mexico’s National Institute for Respiratory Diseases.
María del Carmen Cano-Salas, José L. Miguel-Reyes, Erika C. López-Estrada, Jorge Salas-Hernández, Monserrat E. Arroyo-Rojas, Mauricio Castañeda-Valdivia, Monserrat Escobar-Preciado, Homero Garcés-Flores, Silvia Guzmán- Vázquez, Sergio R. García-García, Herman Soto-Molina   +10 more
doaj   +1 more source

Change in AQLQ(S) following treatment with budesonide pMDI, budesonide/formoterol DPI or budesonide/formoterol pMDI

, 2011
Copyright information:Taken from "Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma"International Journal of Clinical Practice 2007;61(11):1874-1883.Published online Jan 2007PMCID ...
S Peterson (96080), O Beckman (96081), D Osmanliev (96082), A H Morice (96079)   +3 more
core   +1 more source

Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis [PDF]

, 2018
Background: A high percentage of patients with COPD report chronic nasal symptoms. The study aims to evaluate the clinical impact of a 2-month treatment with inhaled nasal budesonide (100 μg per nostril twice daily) in patients affected by COPD with ...
Costigliola A, Leone CA, Tremante E., Merola E., Merola E, Leone C. A., Perna F., Simeon V, Simeon V., Calabrese C., Perna F, Tremante E, Costigliola A., Maffei M, Calabrese C, Maffei M., Bianco A., Bianco A   +17 more
core   +1 more source

Resolving Endoplasmic Reticulum‐Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of Severe Asthma

Allergy, EarlyView.
This study investigates the role of ER stress in steroid resistance in severe asthma. Results from advanced 3D models of human bronchial epithelial cells, steroid‐resistant severe asthma mouse models, and human severe asthma sputum samples show that treatment with ICS in combination with the ER stress inhibitor 4‐PBA significantly enhances steroid ...
Prabuddha S. Pathinayake, Alexandra C. Brown, Nikhil T. Awatade, Philip M. Hansbro, Katherine J. Baines, Richard Y. Kim, Nathan W. Bartlett, Jay C. Horvat, Peter A. B. Wark   +8 more
wiley   +1 more source

Targeted-release budesonide: A comprehensive review on its potential in IgA nephropathy

Heliyon
IgA nephropathy (IgAN) is characterized by the presence of IgA deposits in the glomerular mesangium, representing a prevalent form of primary glomerulonephritis worldwide.
Fei-fan Qi, Hui-qin Zeng, Jian-jiang Zhang   +2 more
doaj   +1 more source

Clearance of corticosteroids in pediatric patients with active eosinophilic esophagitis: Faster than expected. [PDF]

Pediatr Allergy Immunol
Pediatric Allergy and Immunology, Volume 37, Issue 6, June 2026.
Barbosa PFA, Sapienza MT, Pastorino AC, Yang AC, Yonamine GH, de Barros Dorna M, Castro APBM.   +6 more
europepmc   +2 more sources

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo‐Controlled, Phase III Trial

Allergy, EarlyView.
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian, Menglin Wang, Changqing Zhao, Lijia Wan, Yu Xu, Juan Meng, Rui Xu, Xicheng Song, Li Shi, Yucheng Yang, Yan Jiang, Yanzhen Wu, Bethany Ling, Vivian Li, Andrew P. Fontenot, Lacey R. Robinson, Neelam A. Phadke, Chengshuo Wang, Luo Zhang   +18 more
wiley   +1 more source

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients

Pediatrics and Neonatology, 2010
Cytokines and chemokines play important roles in asthma. However, little information exists on the effects of inhaled corticosteroids on cytokine and chemokine plasma levels in childhood asthma.
Lin-Yu Kuo, Chih-Hsing Hung, Hsing-I Tseng, Jiunn-Ren Wu, Yuh-Jyh Jong, Yu-Te Chu   +5 more
doaj   +1 more source

Remission in Global Airway Diseases: EUFOREA Consensus Paper

Allergy, EarlyView.
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow, Xander Bertels, Vibeke Backer, Benjamin S. Bleier, Marco Caminati, Diego M. Conti, Eugenio De Corso, Mina Gaga, Valerie J. Lund, Corrado Pelaia, Anju T. Peters, Glenis K. Scadding, Martin Wagenmann, Riyad O. Al‐Lehebi, Guy G. Brusselle, Philippe Gevaert, Liam G. Heaney, Stella E. Lee, Florence Schleich, Frederik Trinkmann, Peter W. Hellings, Wytske J. Fokkens, Paola Rogliani   +22 more
wiley   +1 more source

Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo

, 2001
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAIMS: The efficacy of topical glucocorticosteroids in rhinitis and asthma is likely to depend on drug retention in the airway mucosa.
Edsbäcker, S, Petersen, H, Annika Kullberg, Greiff, L, Staffan Edsbäcker, Hannes Petersen, Kullberg, A, Lennart Greiff   +7 more
core   +1 more source